〔資 料〕 閉経後女性の体脂肪蓄積，筋肉量および骨密度低下の抑制を 目的とした食事条件を提案するための基礎研究 ―自発運動可能な卵巣摘除メスラットの下肢骨格筋重量，大腿骨骨密度および 走行運動レベルに対する食餌アミノ酸添加の影響―

The present study aims to review whether dietary modifications will prevent body fat accumulation, muscle mass wasting and bone mineral density loss in postmenopausal women who incorporate physical exercise into daily life.9-week-old ovariectomized Wistar strain female rats were divided into four groups: CA-Ex, Gln-Ex, Leu-Ex and CitD-Ex. Depending on which group they were in, the rats were given a 20％ casein protein based experimental diet supplemented with nothing （control diet, CA-Ex）; 5％ of L-glutamine （Gln-Ex）; 5％ of L-leucine （Leu-Ex）; or 2.5％ of L-citrulline＋2.5％ of D-serine （CitD-Ex）, each 11 g per day for 10 weeks. All of these rats were housed in individual cage with a running wheel for 10 weeks. A sham operation was carried out on another group of rats （Sham） and were given the same diet as CA-Ex, the control diet.Results were as follows:1） Uterus weights of the ovariectomized rats, that is group CA-Ex, Gln-Ex, Leu-Ex and CitD-Ex, appeared to show lower values than that of the group Sham. 2） No significant differences were observed in a）changes in body weight, b）blood analyses, c）liver, kidney, uterus and muscle weights, and d）femoral-bone mineral density in groups Gln-Ex, Leu-Ex, and CitD-Ex as compared to the group CA-Ex.3） Relatively higher running activity was observed in group CitD-Ex than that of group CA-Ex. This observation suggests that increasing dietary L-citrulline plus D-serine in postmenopausal rats may lead to an increase in physical activity. Further research is needed to understand the physiological and nutritional significance of the unexpected results that dietary amino acid may accelerate the physical activity

Physiological Study of Visual and Non-Visual Effects of Light Exposure

Light simultaneously induces visual and non-visual effects. Although the differences in the spectral sensitivity of intrinsic photosensitive retinal ganglion cells induce opposing influences on physiological responses, it is difficult to independently measure only non-visual effects. Therefore, the reported effects of light color on physiological responses are inconsistent. This study aimed to clarify the visual and non-visual effects of light color on physiological responses. Three different conditions were employed to construct a lighting environment in which light colors were difficult to perceive due to chromatic adaptation and change blindness: constant white light (baseline condition), a gradual transition from white to blue light, and a gradual transition from white to red light. The physiological responses (brain activity, heart rate variability, and electrodermal activity) of 21 participants were measured with and without light color perception. The results suggested that blue light causes more non-visual effects compared to red light as blue light induces brain activation in some regions of the PFC (p < 0.05) and increases sweating, although the differences were not statistically significant. A mean comparison suggested that the visual effects of blue light showed tendencies toward a calming role for the prefrontal cortex and inhibition of sweating, but the differences were not statistically significant. Another mean comparison suggested that the visual effects of red light tended to enhance sweating, but the differences were not statistically significant. Visual and non-visual effects did not cause significant differences in heart rate variability. Additionally, a mean comparison did not reveal any significant tendencies

A case of severe acalculous cholecystitis associated with sorafenib treatment for advanced hepatocellular carcinoma

Sorafenib, a multikinase inhibitor, is the first and only drug, which improves significantly the overall survival in patients with advanced hepatocellular carcinoma (HCC). However, many patients experience diverse side effects, some of them severe and unexpected. To date, acute acalculous cholecystitis has not been documented in association with a HCC patient treated with sorafenib. Here, we report the case of a 43-year-old woman with hepatitis C virus-related advanced HCC. She received sorafenib, and later complained of a sudden onset of severe right hypocondrial pain with rebound tenderness and muscle defense. Laboratory examination showed mild elevation of transaminases, biliary enzymes, bilirubin, inflammation markers, and a marked peripheral eosinophilia. Abdominal computed tomography (CT) revealed a swollen gallbladder with exudate associated with severe inflammation without stones or debris. Consequently, sorafenib treatment was stopped immediately, and steroid-pulse therapy was performed. Steroid therapy drastically improved all clinical manifestations along with normalization of CT findings, eosinophilia, and liver functions. In summary, we herein report a rare case of acute severe acalculous cholecystitis associated with sorafenib in the patient with advanced HCC

National trends in the outcomes of subarachnoid haemorrhage and the prognostic influence of stroke centre capability in Japan: retrospective cohort study

Objectives To examine the national, 6-year trends in in-hospital clinical outcomes of patients with subarachnoid haemorrhage (SAH) who underwent clipping or coiling and the prognostic influence of temporal trends in the Comprehensive Stroke Center (CSC) capabilities on patient outcomes in Japan.Design Retrospective study.Setting Six hundred and thirty-one primary care institutions in Japan.Participants Forty-five thousand and eleven patients with SAH who were urgently hospitalised, identified using the J-ASPECT Diagnosis Procedure Combination database.Primary and secondary outcome measures Annual number of patients with SAH who remained untreated, or who received clipping or coiling, in-hospital mortality and poor functional outcomes (modified Rankin Scale: 3–6) at discharge. Each CSC was assessed using a validated scoring system (CSC score: 1–25 points).Results In the overall cohort, in-hospital mortality decreased (year for trend, OR (95% CI): 0.97 (0.96 to 0.99)), while the proportion of poor functional outcomes remained unchanged (1.00 (0.98 to 1.02)). The proportion of patients who underwent clipping gradually decreased from 46.6% to 38.5%, while that of those who received coiling and those left untreated gradually increased from 16.9% to 22.6% and 35.4% to 38%, respectively. In-hospital mortality of coiled (0.94 (0.89 to 0.98)) and untreated (0.93 (0.90 to 0.96)) patients decreased, whereas that of clipped patients remained stable. CSC score improvement was associated with increased use of coiling (per 1-point increase, 1.14 (1.08 to 1.20)) but not with short-term patient outcomes regardless of treatment modality.Conclusions The 6-year trends indicated lower in-hospital mortality for patients with SAH (attributable to better outcomes), increased use of coiling and multidisciplinary care for untreated patients. Further increasing CSC capabilities may improve overall outcomes, mainly by increasing the use of coiling. Additional studies are necessary to determine the effect of confounders such as aneurysm complexity on outcomes of clipped patients in the modern endovascular era